Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5272175
Max Phase: Preclinical
Molecular Formula: C26H31N3O5S
Molecular Weight: 497.62
Associated Items:
ID: ALA5272175
Max Phase: Preclinical
Molecular Formula: C26H31N3O5S
Molecular Weight: 497.62
Associated Items:
Canonical SMILES: COc1ccc(S(=O)(=O)N(C)c2c(C)cc(Cc3ccc(CN(C)C)cc3)cc2C(=O)NO)cc1
Standard InChI: InChI=1S/C26H31N3O5S/c1-18-14-21(15-19-6-8-20(9-7-19)17-28(2)3)16-24(26(30)27-31)25(18)29(4)35(32,33)23-12-10-22(34-5)11-13-23/h6-14,16,31H,15,17H2,1-5H3,(H,27,30)
Standard InChI Key: AYTZJEWKGLEPFF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 497.62 | Molecular Weight (Monoisotopic): 497.1984 | AlogP: 3.60 | #Rotatable Bonds: 9 |
Polar Surface Area: 99.18 | Molecular Species: BASE | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.60 | CX Basic pKa: 9.21 | CX LogP: 3.32 | CX LogD: 2.40 |
Aromatic Rings: 3 | Heavy Atoms: 35 | QED Weighted: 0.35 | Np Likeness Score: -0.98 |
1. Mondal S, Adhikari N, Banerjee S, Amin SA, Jha T.. (2020) Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview., 194 [PMID:32224379] [10.1016/j.ejmech.2020.112260] |
Source(1):